Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012
Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012
Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012
Submitted by
admin
on January 27, 2012 - 11:08am
Source:
Seeking Alpha
News Tags:
Alexion
Amgen
Ariad
Biogen Idec
Bristol-Myers Squibb
Celgene
Gilead
Illumina
Inhibitex
Vertex Pharmaceuticals
Headline:
Biotech Equities Continue To Benefit From Discoveries And Acquisitions In 2012
Do Not Allow Advertisers to Use My Personal information
